Bank Pictet & Cie (Europe) AG - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Bank Pictet & Cie (Europe) AG ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$259,623
-58.8%
6,825
-1.4%
0.01%
-57.1%
Q2 2023$630,321
+30.2%
6,919
-5.7%
0.02%
+5.0%
Q1 2023$484,212
+28.9%
7,341
+1.1%
0.02%
+11.1%
Q4 2022$375,518
-99.9%
7,262
-0.5%
0.02%
-28.0%
Q3 2022$498,385,000
+150925.8%
7,2970.0%0.02%
+66.7%
Q2 2022$330,000
-28.4%
7,297
-19.5%
0.02%
-16.7%
Q1 2022$461,000
+53.7%
9,069
+43.2%
0.02%
+80.0%
Q4 2021$300,000
-47.5%
6,335
-29.9%
0.01%
-50.0%
Q2 2021$571,000
+68.9%
9,041
+14.7%
0.02%
+42.9%
Q1 2021$338,0007,8810.01%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 2,503,059$170,959,00029.50%
ACUTA CAPITAL PARTNERS, LLC 554,000$37,838,00016.29%
Avoro Capital Advisors LLC 10,125,000$691,538,00012.78%
Sio Capital Management, LLC 507,700$34,676,00011.02%
Logos Global Management LP 1,300,000$88,790,00010.92%
EcoR1 Capital, LLC 5,183,431$354,028,00010.45%
Cormorant Asset Management, LP 1,478,000$100,947,0007.06%
Finepoint Capital LP 266,090$18,174,0005.98%
Ghost Tree Capital, LLC 275,000$18,783,0005.27%
Boxer Capital, LLC 1,303,700$89,043,0005.01%
View complete list of APELLIS PHARMACEUTICALS INC shareholders